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p-Azidophenylglyoxal (APG), a heterobifunctional reagent with one group reacting selectively with arginine r sidues and 
another group photoactivable, w s used to cross-link [~2SI]secretin prebound to intact r t pancreatic acini. The best yi ld 
was obtained when the pzSI]secretin-acini omplex was incubated under im light with 2 mM APG at37°C and pH 8.0, 
followed by photolysis at 312 nm. The main secretin binding peptide cross-linked under educing conditions, when tested 
by SDS-PAGE and autoradiography: (i) had a molecular mass of 51 kDa and was not a subunit of a larger disulfide- 
linked structure, and (ii) was distinct from the main VIP binding peptide coex sting inthe same preparation. 
Secretin receptor; Azidophenylglyoxal, p-; (Rat pancreas) 
1. INTRODUCTION 
Secretin-preferring and VIP-preferring receptors 
coexist in intact rat pancreatic acini. They are en- 
dowed with overlapping affinities for agonists so 
that competition binding curves extend over more 
than 3 logarithms [1,2]. The same holds true in rat 
pancreatic membranes [3]. We recently showed 
that the main VIP binding site in intact rat pan- 
creatic acini has a molecular mass of 77 kDa by 
acylating amino group(s) in both 125I-VIP and its 
receptor with bifunctional cross-linking agents ac- 
ting through N-hydroxysuccinimide ester groups 
[4]. The Present study gives the first information 
about the molecular architecture of secretin recep- 
tors in intact pancreatic acini using a photoaffinity 
labelling approach. Porcine secretin has no lysine 
residues and its N-terminal histidine is directly in- 
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volved in receptor recognition ([5,6] and un- 
published observations). Such an absence of free 
amino groups readily available in secretin prevents 
the testing of the cross-linkers we used for VIP 
receptors. On the other hand secretin contains four 
arginine residues o that we were persuaded to test 
p-azidophenylglyoxal (APG). This arylglyoxal is 
an ultraviolet-sensitive h terobifunctional reagent 
highly specific for arginine in its dione (a- 
dicarbonyl) moiety [7,8]. We reasoned that, after 
reversible [125I]secretin binding to intact rat pan- 
creatic acini, the glyoxal function of APG would 
react, under mild conditions, with the bifunctional 
nitrogen nucleophile of the guanidinium group in 
those arginine residues of the radioligand that were 
not directly involved in receptor ecognition. The 
adduct formed would be a double carbinolamine 
with vicinal cis-hydroxyl groups. In the next step 
the still reversibly bound secretin derivative(s) 
could be irreversibly cross-linked to secretin recep- 
tors, after UV photoactivation of the azidophenyl 
group of APG, the reactive nitrene generated 
forming linkage with virtually any part of nearby 
binding sites. A similar approach ad already been 
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successfully undertaken for VIP receptors in liver 
plasma membranes [9]. 
2. MATERIALS  AND METHODS 
[L25I]Secretin was prepared with synthetic porcine secretin by 
minor modifications of the method of Jensen et al. [10] as 
described in [1,3] (labelling of the N-terminal histidine residue 
was initiated chloramine T). [125I]Secretin corresponded to a 
single homogeneous peak after reverse phase HPLC on a/~Bon- 
dapak C-18 column with a 25-40°70 acetonitrile gradient con- 
taining 0.1070 trifluoroacetic acid. It was diluted in 10 mM 
phosphate buffer (pH 7.4)-150 mM NaCl enriched with 0.1 070 
NaN3 and 0.5%o Tween 20, was tored frozen at -20°C, and 
could be used over a 2 month period. 
Dispersed acini from male Wistar rats (150-200 g) were 
prepared as in [1] and incubated for 45 min at 37°C with 
0.5 nM [12~I]secretin (35 TBq/mmol) in 25 mM Dulbecco- 
Hepes medium supplemented with 2070 bovine serum albumin, 
0.1070 bacitracin and 0.1070 soybean trypsin inhibitor (STI). 
After binding equilibrium [1] the acini were washed four times 
by centrifugation/resuspension in cold PBS (10 mM phosphate 
buffer (pH 7.4)-145 mM NaCl) and resuspended in 25 mM 
borate-8 mM phosphate buffer (pH 8.0) at a 40 mg wet wt/ml 
concentration. 1 vol. APG solution was added to 99 vols of the 
acini suspension. APG was dissolved immediately before use in 
dry dimethylsulfoxide. After 15 min of incubation under dim 
light at the indicated temperature the acini were washed twice 
by centrifngation/resuspension in cold PBS, resuspended in 
PBS as above and exposed for 15 min at 4°C to a 6 W UV lamp 
(Lab Center, Ankersmit) wavelength 312 nm, at 10 cm. 
Illuminated acini were centrifuged and the pellet was 
disrupted by sonification in a lysis buffer made of 10 mM Tris- 
HC1 (pH 7.4), 1 mM EDTA, 0.25 M sucrose, 0.1070 bacitracin 
and 0.01°/0 STI. Following centrifngation at 1000 x g for 
10 rain, the resulting supernatant was recentrifuged for 20 min 
at 50000 x g (in a J2-21 Beckman centrifuge) to obtain a crude 
membrane fraction. This second pellet, less overloaded with 
nuclear and zymogen granule proteins hanthe first one, was 
solubilized in an electrophoresis sample buffer made of 
0.125 M Tris-HCl (pH 6.8) containing 5070 SDS, 10070 sucrose, 
0.02% bromophenol blue and nriched with 1°70 dithiothreitol 
and 4°70 2-mercaptoethanol. 
SDS-PAGE under educing conditions was performed as in 
[4] with a 5-20070 gradient polyacrylamide separating gel (180 × 
200 x 1.5 mm). Autoradiography (conducted for 6 weeks at 
-80°C), protein determination, andthe origin of chemicals 
were as in [4]. Synthetic porcine secretin was a generous gift 
from Dr W. K6nig (Hoechst Aktiengesellschaft, 
Frankfurt/Main, FRG). 
3. RESULTS 
Pretreating at 37°C the [125I]secretin-intact ini 
complex with 2 mM APG at pH 8.0 or 9.0 (fig. 1, 
lanes 5 and 11, respectively), provoked the incor- 
porat ion of radioactivity into a major  54 kDa pep- 
tide. When provision is made for the molecular 
Fig.1. Cross-linking of [~2~I]secretin to rat pancreatic acini. 
Acini were incubated with [~2~I]secretin in 1 ml aliquots, inthe 
absence or presence of 1/zM unlabelled secretin. Washed acini 
were incubated for 15 min at 4, 20 or 37°C and at pH 8 or 9 
in the presence of 1 mM APG. Further treatment was as 
described in section 2. 
mass of secretin this suggests that the 51 kDa pep- 
tide was a part of the binding site. A faint 
180-220 kDa secretin binding smear was also 
detectable under our reducing condit ions 
( f ig . l -3) .  Labell ing was fully inhibited when the 
radiol igand was incubated in the presence of 1/~M 
secret in  (fig. 1, lanes 6 and 12) and suppressed in 
the absence of APG or UV, while being unaffected 
after incubat ion in the presence of 1/~M vasoactive 
intestinal peptide (VIP) and 1/zM peptide 
histidine-isoleucinamide (PHI)  (not shown). Fig. 1 
also shows that the optimal temperature was 37°C, 
secretin cross-linking being feeble at 20°C (lanes 3 
and 9), and nonexistent a 4°C (lanes 1 and 7): this 
temperature of 37°C was a middle ground for op- 
t imai adduct formation of APG with arginine 
residues, in the face of the dissociation of secretin 
not yet cross-linked to its receptor. 
When comparing 3 APG concentrations (5, 2, 
and 0.5 mM), the cross-linking of the main 54 kDa 
peptide was most specific with 2 mM APG (fig.2). 
We next tested the effects of pH on cross-linking. 
Theoret ica l ly ,  the reaction with a glyoxal is 
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Fig.2. Effects of APG concentration on the cross-linking of 
[m25I]secretin to rat pancreatic acini. Acini were incubated with 
[~25I]secretin in the absence or presence of 1/~M unlabelled 
secretin. Washed acini were incubated for 15 min at 37°C in the 
presence of 0.5, 2 or 5 mM APG. Further treatment was as 
described in section 2. 
facilitated when arginine is deprotonated i.e. at an 
unphysiologically high alkaline pH [8]. Under our 
conditions, the optimal pH was around 8.5 (fig.3, 
lane 7), an obvious compromise between optimal 
APG reaction with arginine residues in secretin 
and increasing dissociation of  the hormone from 
intact receptors. 
Finally (fig.4) secretin in the incubation medium 
competitively inhibited [125I]secretin cross-linking 
to intact acini with an ICso of  31 nM for both the 
main 51 kDa band and the smearing 200 kDa 
material. This ICs0 value was comparable to the 
IC5o value o f  reversible [125I]secretin binding to 
dispersed rat acini [1] but could differ f rom the 
true Ki by, e.g. an unusually high affinity of  the 
tracer and/or  the relatively high concentration of  
tracer (0.5 nM) we used to obtain enough 
labelling. 
Fig.3. Effects of pH on the cross-linking of ['2Sl]secretin o rat 
pancreatic acini. Preincubated acini were suspended in l ml 
aliquots of 25 mM borate buffer adjusted to the indicated pH 












Fig.4. Inhibition of [~z~I]secretin cross-linking to rat pancreatic 
acini by increasing secretin concentrations in the preincubation 
medium. The general procedure is described in section 2. 
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4. DISCUSSION 
Our photoaffinity probe of secretin binding sites 
was prepared by cross-linking prebound 
[125I]secretin with APG, at 37°C and at pH 8.0. 
The conditions used maintained probably intact 
the plasma membranes of dispersed acini. 
However, the yield was very low and more than 
one month exposures were necessary to visualize 
the cross-linked secretin. We were unable to cross- 
link [125I]secretin to semi-purified rat pancreatic 
plasma membranes probably as a result of receptor 
inactivation during the long cross-linking pro- 
cedure. 
The 51 kDa peptide we observed appeared 
distinct from the 62 kDa binding site observed [11] 
in plasma membrane preparations from rat antrum 
(in addition to a 33 kDa peptide) when using a 
cleavable chemical homobifunctional cross-linker 
(dithiobis(succinimidyl)propionate). The molecu- 
lar mass of the present secretin binding peptide was 
also definitely lower than the molecular mass of 
60-80 kDa of VIP binding peptides in rat pan- 
creatic acini [4], rat tumoral pancreatic acinar cells 
AR 4-2J [12], rat and human intestinal epithelium, 
the human colonic HT-29 cell line, the main bin- 
ding site of rat liver membranes, and membranes 
from human, rabbit and guinea pig lung. This 
molecular mass was more similar to that of other 
also unrelated VIP binding peptides characterized 
in rat liver and lung membranes, rat GH 3 pituitary 
cells and in human lymphoblasts (review [4]). 
A variable proportion of a minor smearing 
material in the 180-220 kDa range could represent 
covalent linkage, at 37°C, and under conditions 
excluding interchain disulfide bridges between 
[125I]secretin, its receptor, and neighboring pro- 
teins including those of the adenylate cyclase 
complex. 
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